[Primary cytomegalovirus infection causing a kidney transplant patient to develop cryoagglutinins and cryoglobulins].
Fernández
E J
EJ
Auyanet
I
I
Guerra
R
R
Pérez
M A
MA
Bosch
E
E
Ramírez
A
A
Suria
S
S
Checa
M D
MD
D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use; D003449:Cryoglobulinemia / Q000209:etiology*; D003450:Cryoglobulins / Q000032:analysis*; D003586:Cytomegalovirus Infections / Q000097:blood / Q000150:complications* / Q000517:prevention & control; D005260:Female; D015774:Ganciclovir / Q000031:analogs & derivatives / Q000627:therapeutic use; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000627:therapeutic use; D006801:Humans; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000009:adverse effects; D007244:Infectious Mononucleosis / Q000097:blood / Q000150:complications*; D016030:Kidney Transplantation; D007970:Leukopenia / Q000188:drug therapy / Q000209:etiology; D011183:Postoperative Complications / Q000097:blood / Q000209:etiology* / Q000276:immunology; D000077562:Valganciclovir
D000998:Antiviral Agents; D003450:Cryoglobulins; D007166:Immunosuppressive Agents; C029443:cold agglutinins; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D000077562:Valganciclovir; D015774:Ganciclovir